PharmaCyte Biotech Cash Flow Statement (2010-2026) | PMCB

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jul2010 Oct2010 Jan2011 Apr2011 Jul2011 Oct2011 Jan2012 Apr2012 Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Jan2014 Apr2014 Jul2014 Oct2014 Jan2015 Apr2015 Jul2015 Oct2015 Jan2016 Apr2016 Jul2016 Oct2016 Jan2017 Apr2017 Jul2017 Oct2017 Jan2018 Apr2018 Jul2018 Oct2018 Jan2019 Apr2019 Jul2019 Oct2019 Jan2020 Apr2020 Jul2020 Oct2020 Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026
Operating Activities
Net Income (Quarter)
-1.03M-1.02M-0.98M-0.81M-1.42M-1.54M-1.88M-0.92M-0.18M-1.20M-0.52M-0.99M6.17M-0.72M-0.72M-0.70M10.00M-0.63M-1.17M-1.89M
Share-based Compensation (Quarter)
0.13M0.01M88.000.01M0.00M0.00M0.91M0.67M-0.91M0.22M0.12M0.07M0.48M0.06M0.06M0.06M
Gains from Sales and Divestitures (Quarter)
0.01M0.00M0.01M0.01M0.00M0.00M0.00M0.00M
Gains from Investment Securities (Quarter)
0.00M333.000.05M-0.00M0.04M0.28M0.28M0.28M0.13M0.19M0.00M0.01M0.15M0.00M2.97M
Non-cash Items (Quarter)
0.03M0.02M0.01M0.01M0.01M0.00M0.04M0.28M0.28M0.25M334.000.25M0.64M0.06M0.92M0.92M0.91M0.91M
Cash from Operations (Quarter)
-0.94M-1.24M-1.39M-0.30M-1.19M-1.08M-1.88M-0.54M-0.29M0.34M-1.98M-0.18M-0.33M-0.37M-1.05M-0.51M-1.04M-1.99M-0.98M-0.79M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Depreciation & Amortization (CF) (Quarter)
Change in Working Capital
Change in Receivables (Quarter)
Change in Inventory (Quarter)
Change in Account Payables (Quarter)
0.09M-0.01M-0.01M-0.06M0.11M0.35M0.30M-0.58M-0.32M0.59M-0.59M0.36M-0.09M0.16M-0.21M0.14M-0.09M0.07M0.47M0.18M
Change in Accured Expenses (Quarter)
0.01M-0.02M-0.50M0.49M0.03M0.03M-0.08M-0.07M0.08M0.02M0.27M-0.25M0.14M-0.06M0.01M1.001.36M-1.01M-0.07M-0.54M
Investing Activities
Change in Intangibles (Quarter)
Acquisitions (Quarter)
Cash from Investing Activities (Quarter)
-5.00M-7.00M-3.00M5.00M
Financing Activities
Other financing activities (Quarter)
0.01M0.01M0.01M0.01M0.00M0.00M0.00M667.002.26M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Long-Term Debt Repayments (Quarter)
-0.05M0.05M
Change in Capital Stock
Shares Issued (Quarter)
44.97M-24.02M-31.67M880.0070.00
Shares Repurchased (Quarter)
2.09M3.39M3.78M4.31M26.46M0.16M0.40M1.17M0.74M1.40M0.23M0.17M0.40M
Preferred Shares Issued (Quarter)
35.00M-1.35M
Preferred Shares Repurchased (Quarter)
6.64M9.52M9.43M9.34M3.72M
Misc.
Cash from Financing Activities (Quarter)
0.05M87.36M-0.05M-2.09M-3.39M-3.78M-4.31M6.28M0.75M-7.04M-10.70M-10.17M-10.74M-3.95M-0.17M6.21M0.54M
Exchange Rate Effect (Quarter)
633.00-0.00M0.00M-210.000.00M0.00M-720.00-0.00M-0.01M451.00-0.00M0.00M-438.00183.0061.00-0.00M617.00123.00-381.000.00M
Change in Cash (Quarter)
-0.89M-1.24M85.98M-0.30M-1.24M-3.17M-5.27M-4.32M-4.60M6.62M-1.24M-12.21M-11.03M-17.54M-11.80M-4.46M-1.21M-1.99M2.23M4.76M
Beginning Cash Balance (Quarter)
Free Cash Flow (Quarter)
-0.94M-1.24M-1.39M-0.30M-1.19M-1.08M-1.88M-0.54M-0.29M0.34M-1.98M-0.18M-0.33M-0.37M-1.05M-0.51M-1.04M-1.99M-0.98M-0.79M
Net Cash Flow (Quarter)
-0.89M-1.24M85.98M-0.30M-1.24M-3.17M-5.26M-4.32M-4.60M6.62M-1.24M-12.22M-11.03M-17.55M-11.80M-4.46M-1.21M-1.99M2.23M4.76M